Skip to content

DexCom DXCM Q4 2024 Annual earnings

Reported February 13, 2025 · After market close

Revenue estimate$1.1B
EPS estimate$0.48

Next report

Jul 29, 2026 (In 2 weeks)
Revenue estimate$1.3B
EPS estimate$0.61

Financials

Q4 2024

Income statement

See full
Revenue$1.1B+7.6%
Gross profit$655.8M-0.1%
Operating income$188.9M-12.9%
Net income$151.7M-40.8%
EPS (diluted)$0.38-37.7%

Balance sheet

See full
Cash & equivalents$607.3M+7.0%
Total debt$152.4M-7.4%
Total equity$2.1B+1.6%
Total assets$6.5B+3.5%

Cash flow

See full
Operating cash flow$301.4M+126%
CapEx$124.6M+137%
Free cash flow$176.8M+118%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$30.38B-35.9%
Enterprise value$29.92B-36.3%
P/E52.7×-34.7×
P/S7.5×-5.5×

Profitability

See full
Gross margin60.5%-2.7pp
Operating margin14.9%-1.6pp
Net margin14.3%-0.7pp
FCF margin15.6%+1.5pp

Returns & leverage

See full
Return on equity27.6%+1.8pp
Debt / equity0.1×0.0×
Current ratio1.5×-1.4×

Segments

By geography

See full
United States$802.8M+4.4%

Versus estimates

Ask the moment DexCom reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did DexCom report Q4 2024 earnings?
DexCom (DXCM) reported Q4 2024 earnings on February 13, 2025 after market close.
What were DexCom's Q4 2024 revenue and EPS?
DexCom reported revenue of $1.1B and diluted EPS of $0.45 for Q4 2024.
Did DexCom beat estimates in Q4 2024?
Revenue beat the consensus estimate of $1.1B by $4.4M. EPS missed the consensus estimate of $0.48 by $0.03.
Where can I find DexCom's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001093557-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.